European journal of gynaecological oncology · 2011
Neuroendocrine carcinoma of the uterine cervix: a single institution case review.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Niu X, Gilbert L
Аннотация
OBJECTIVES: To investigate the clinicopathologic features and prognostic factors of neuroendocrine carcinoma of the cervix (NECC).
STUDY DESIGN: All patients with NECC diagnosed between January 1990 and December, 2007 identified from the tumor registry and gynecological oncology databases at McGill University Health Centre comprised this series.
RESULTS: Eleven cases were encountered. Four patients were FIGO Stage Ib1, one Stage Ib2, one Stage IIa, and the other five were advanced stages (III or IV). Ten patients had marked lymph vascular space invasion. Metastasis to the pelvic or paraortic nodes was observed in eight patients. Seven patients were treated by surgery followed by adjuvant chemoradiation, another two had chemoradiation and the other two only received palliative treatments. The median survival was 18 months. All three long-term survival patients were Stage Ib1 without lymph node involvement.
CONCLUSION: NECC is an aggressive tumor with poor prognosis, and only early stages are potentially curable.
STUDY DESIGN: All patients with NECC diagnosed between January 1990 and December, 2007 identified from the tumor registry and gynecological oncology databases at McGill University Health Centre comprised this series.
RESULTS: Eleven cases were encountered. Four patients were FIGO Stage Ib1, one Stage Ib2, one Stage IIa, and the other five were advanced stages (III or IV). Ten patients had marked lymph vascular space invasion. Metastasis to the pelvic or paraortic nodes was observed in eight patients. Seven patients were treated by surgery followed by adjuvant chemoradiation, another two had chemoradiation and the other two only received palliative treatments. The median survival was 18 months. All three long-term survival patients were Stage Ib1 without lymph node involvement.
CONCLUSION: NECC is an aggressive tumor with poor prognosis, and only early stages are potentially curable.